EDAP will release Q4 and full-year 2025 financial results on March 25, 2026, followed by a conference call.
Quiver AI Summary
EDAP TMS SA, a leader in robotic energy-based therapies, announced it will release its financial results for the fourth quarter and full year ending December 31, 2025, on March 25, 2026, before the market opens. CEO Ryan Rhodes, CFO Ken Mobeck, and Chief Accounting Officer François Dietsch will host a conference call and webcast on the same day at 8:30 a.m. EDT. Interested parties can find dial-in details and webcast registration information in the announcement. EDAP is known for its development of minimally invasive medical devices utilizing ultrasound technology, including the Focal One® system for prostate cancer therapy.
Potential Positives
- EDAP TMS is set to announce its fourth quarter and full year 2025 financial results, indicating a commitment to transparency and investor relations.
- The conference call and webcast provide an opportunity for direct engagement with company leadership, enhancing communication with stakeholders.
- The company is recognized as a leader in robotic energy-based therapies, which supports its reputation and market position in the medical device industry.
- EDAP TMS is actively expanding the applications of its Focal One® technology, which may enhance future growth potential beyond prostate cancer treatments.
Potential Negatives
- Announcing financial results for a future date may indicate a lack of confidence if results are expected to be unfavorable, creating uncertainty for investors.
- The specific mention of only prostate focal therapy could signal limited growth potential if expansion into other markets or indications does not materialize.
- Potential proactive measures or updates on business strategy are absent, raising concerns about the company's future direction and innovation plans.
FAQ
When will EDAP announce its fourth quarter financial results?
EDAP will announce its fourth quarter and full year 2025 financial results on March 25, 2026.
What time is the EDAP conference call on March 25?
The conference call will be held at 8:30 a.m. EDT on March 25, 2026.
How can I join the EDAP conference call?
You can join the conference call by dialing 1-800-579-2543 for domestic or 1-785-424-1789 for international access.
Where can I find the webcast for EDAP's financial results announcement?
The webcast can be accessed at https://viavid.webcasts.com/starthere.jsp?ei=1751611&tp_key=27ba007fb5.
What technologies does EDAP TMS focus on?
EDAP TMS focuses on robotic energy-based therapies, utilizing ultrasound technology for minimally invasive medical devices.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$EDAP Hedge Fund Activity
We have seen 4 institutional investors add shares of $EDAP stock to their portfolio, and 17 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- APIS CAPITAL ADVISORS, LLC removed 226,288 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $518,199
- US BANCORP \DE\ added 119,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $391,510
- CITADEL ADVISORS LLC removed 48,251 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $158,745
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 43,692 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $143,746
- SCHONFELD STRATEGIC ADVISORS LLC removed 31,477 shares (-18.5%) from their portfolio in Q4 2025, for an estimated $103,559
- UBS GROUP AG removed 26,689 shares (-11.2%) from their portfolio in Q4 2025, for an estimated $87,806
- ROCK SPRINGS CAPITAL MANAGEMENT LP added 16,500 shares (+1.3%) to their portfolio in Q4 2025, for an estimated $54,285
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
Company to host conference call and webcast on Wednesday, March 25 at 8:30 a.m. EDT
AUSTIN, Texas, March 4, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, before market open on Wednesday, March 25, 2026.
An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.
Call Details:
Date: Wednesday, March 25 th
Time: 8:30 a.m. EDT
Domestic: 1-800-579-2543
International: 1-785-424-1789
Passcode: EDAP
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1751611&tp_key=27ba007fb5
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes, and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics, and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and the United States as a leading prostate focal therapy controlled by urologists, with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com .
Investor Contacts
Investor Relations
EDAP TMS SA
[email protected]
